Author:
Aspinall Sherrie L.,Smith Kenneth J.,Good Chester B.,Zhao Xinhua,Stone Roslyn A.,Tonnu-Mihara Ivy Q.,Cunningham Francesca E.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Reference21 articles.
1. Aspinall SL, Cunningham FE, Zhao X, Boresi JS, Tonnu-Mihara IQ, Smith KJ, Stone RA. Good CB for the ESA Clinic Study Group: impact of pharmacist-managed erythropoiesis-stimulating agents clinics for non-dialysis chronic kidney disease patients. Am J Kidney Dis. 2012;60:371–9.
2. Clapp SE, Bardo JA, Chrymko MM. Implementation of a pharmacist-managed clinic for patients receiving erythropoietin-stimulating agents. Am J Health Syst Pharm. 2008;65(15):1458–63.
3. Gilreath JA, Sageser DS, Jorgenson JA, Rodgers GM. Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients. JNCCN. 2008;6(6):577–84.
4. Kimura T, Arai M, Masuda H, Kawabata A. Impact of a pharmacist-implemented anemia management in outpatients with end-stage renal disease in Japan. Biol Pharm Bull. 2004;27(11):1831–3.
5. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献